Search - tctmd.com

Displaying 61 - 80 of 120

Sort: Relevancy | Date

News Daily News

FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM

Caitlin E. Cox

January 03, 2020

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

January 02, 2020

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Conference News TCT 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Caitlin E. Cox

October 08, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Conference News ESC 2019

CLARIFY at 5 Years: Angina Predictive of MI/CV Death Only in Prior MI Patients

Shelley Wood

September 03, 2019

News Daily News

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Shelley Wood

August 05, 2019

News Conference News ESC Heart Failure 2019

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

Shelley Wood

May 28, 2019

Presentation ARCH 2019

Critical Limb Ischemia: What Tools are Necessary to Treat?

Presenter: S. Jay Mathews

April 12, 2019

Presentation ACC 2019

Blinded Physiological Assessment of Residual Ischemia after Successful Angiographic PCI

Presenter: Allen Jeremias

March 18, 2019

News Conference News ESC 2018

VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS

Todd Neale

August 29, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

Michael O'Riordan

May 29, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

News Industry News

Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease

April 11, 2018

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

Advertisement

FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

CLARIFY at 5 Years: Angina Predictive of MI/CV Death Only in Prior MI Patients

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

Critical Limb Ischemia: What Tools are Necessary to Treat?

Blinded Physiological Assessment of Residual Ischemia after Successful Angiographic PCI

VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content